Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Callan Jmb (CJMB) Cash & Equivalents (2023 - 2025)

Callan Jmb's Cash & Equivalents history spans 3 years, with the latest figure at $2.8 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents changed N/A year-over-year to $2.8 million; the TTM value through Sep 2025 reached $2.8 million, changed N/A, while the annual FY2024 figure was $2.1 million, 59.31% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $2.8 million at Callan Jmb, down from $4.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $5.2 million in Q1 2025 and bottomed at $2.1 million in Q4 2024.
  • The 3-year median for Cash & Equivalents is $4.2 million (2025), against an average of $3.9 million.
  • The largest YoY upside for Cash & Equivalents was 59.31% in 2024 against a maximum downside of 59.31% in 2024.
  • A 3-year view of Cash & Equivalents shows it stood at $5.2 million in 2023, then crashed by 59.31% to $2.1 million in 2024, then surged by 32.98% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for CJMB's Cash & Equivalents are $2.8 million (Q3 2025), $4.2 million (Q2 2025), and $5.2 million (Q1 2025).